The Mycetoma Knowledge Gap: Identification of Research Priorities

PLoS Neglected Tropical Diseases

Volumn 8, Issue 3, 2014, Pages

  van de Sande, Wendy W J ^a   Maghoub, El Sheikh ^b   Fahal, Ahmed H ^b   Goodfellow, Michael ^c   Welsh, Oliverio ^d   Zijlstra, Ed ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^e Rotterdam Centre for Tropical Medicine   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; COTRIMOXAZOLE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; STREPTOMYCIN; SULFAMETHOXAZOLE; VORICONAZOLE;

AFRICAN TRYPANOSOMIASIS; ARTICLE; DISEASE TRANSMISSION; FOLLOW UP; HEALTH EDUCATION; HUMAN; IMMUNE SYSTEM; INCIDENCE; META ANALYSIS (TOPIC); MINIMUM INHIBITORY CONCENTRATION; MYCETOMA; PREVALENCE; SCHISTOSOMIASIS; WORLD HEALTH ORGANIZATION;

BIOMEDICAL RESEARCH; HUMANS; INCIDENCE; MYCETOMA; NEGLECTED DISEASES; PREVALENCE; RESEARCH; TROPICAL CLIMATE; TROPICAL MEDICINE;

EID: 84897428987     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002667     Document Type: Article

References (84)

1. WHO (2013) The 17 neglected tropical diseases. Geneva: World Health Organization.
2. Merritt RW, Walker ED, Small PL, Wallace JR, Johnson PD, et al. (2010) Ecology and transmission of Buruli ulcer disease: a systematic review. PLOS Negl Trop Dis 4: e911.
3. Van de Sande WWJ, (2013) Global burden of human mycetoma: a systematic review and meta-analysis. PLOS Negl Trop Dis 7: e2550.
4. Queiroz-Telles F, Nucci M, Colombo AL, Tobon A, Restrepo A, (2011) Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol 49: 225-236.
5. Ahmed AO, van Leeuwen W, Fahal A, van de Sande WWJ, Verbrugh H, et al. (2004) Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 4: 566-574.
6. Kaempfer E (1694) Disputatio physica medica inauguralis exhibens decadem observationem exoticarum [phD thesis]. Netherlands: Univeristy of Leiden.
7. Fahal AH, Sabaa AH, (2010) Mycetoma in children in Sudan. Trans R Soc Trop Med Hyg 104: 117-121.
8. Abbott P, (1956) Mycetoma in the Sudan. Trans R Soc Trop Med Hyg 50: 11-24 discussion, 24-30.
9. Lynch JB, (1964) Mycetoma in the Sudan. Ann R Coll Surg Engl 35: 319-340.
10. Develoux M, Audoin J, Treguer J, Vetter JM, Warter A, et al. (1988) Mycetoma in the Republic of Niger: clinical features and epidemiology. Am J Trop Med Hyg 38: 386-390.
11. Bakshi R, Mathur DR, (2008) Incidence and changing pattern of mycetoma in western Rajasthan. Indian J Pathol Microbiol 51: 154-155.
12. Maiti PK, Ray A, Bandyopadhyay S, (2002) Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health 7: 788-792.
13. Chakraborti A, Singh K, (1998) Mycetoma in Chandigarh and surrounding areas. Indian J Med Microbiol 16: 64-65.
14. Lopez Martinez R, Mendez Tovar LJ, Lavalle P, Welsh O, Saul A, et al. (1992) [Epidemiology of mycetoma in Mexico: study of 2105 cases]. Gac Med Mex 128: 477-481.
15. Joshi KR, Sanghvi A, Vyas MC, Sharma JC, (1987) Etiology & distribution of mycetoma in Rajasthan, India. Indian J Med Res 85: 694-698.
16. Buot G, Lavalle P, Mariat F, Suchil P, (1987) [Epidemiologic study of mycetomas in Mexico. Apropos of 502 cases]. Bull Soc Pathol Exot Filiales 80: 329-339.
17. Culligan GA, Grant C, Robbs GM, Crewe-Brown HH, (1985) Actinomadura pelletieri mycetoma from the Transvaal. A case report. S Afr Med J 68: 416-418.
18. Freed CC, Bissett E, Martin PM, Ajello L, (1975) Actinomycotic mycetoma due to Streptomyces somaliensis: report of a case in South Africa. Sabouraudia 13: 316-322.
19. Vismer HF, Morrison JG, (1974) Mycetoma caused by Actinomadura (Streptomyces) madurae. The first South African case and the results of chemotherapy. S Afr Med J 48: 433-437.
20. Murray IG (1968) Laboratory aspects of mycetoma. In: Wolstenholme GEW, editor. Systemic mycosis. London, WI: J. & A. Churchill Ltd. pp. 78-93.
21. The Federal Ministry of Health: The National Mycetoma Control Programme (2010) Report on the Epidemiological Study on Mycetoma at El Andalous Village, The White Nile State. Available: http://mycetoma.uofk.edu/news%26events/pdf/AL%20Andalous%20final%20report.pdf. Accessed 19 February 2014.
22. Porten K, Sailor K, Comte E, Njikap A, Sobry A, et al. (2009) Prevalence of Buruli ulcer in Akonolinga health district, Cameroon: results of a cross sectional survey. PLOS Negl Trop Dis 3: e466.
23. Phanzu DM, Suykerbuyk P, Imposo DB, Lukanu PN, Minuku JB, et al. (2011) Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo. PLOS Negl Trop Dis 5: e1402.
24. BNNICD (2012) Blue Nile Institute for Communicable diseases (BNNICD) newsletter. Wad Medani: Blue Nile Institute for Communicable Diseases. 3 p.
25. Segretain G, Mariat F, (1968) [Research on the presence of agents of mycetoma in the soil and thorny plants of Senegal and Mauritania]. Bull Soc Pathol Exot Filiales 61: 194-202.
26. Parthasarathi K, Ranganathan LS, Anandi V, Zeyer J, (2007) Diversity of microflora in the gut and casts of tropical composting earthworms reared on different substrates. J Environ Biol 28: 87-97.
27. Orchard VA, Goodfellow M, (1980) Numerical classification of some named strains of Nocardia asteroides and related isolates from soil. J Gen Microbiol 118: 295-312.
28. Gonzalez-Ochoa A, Sandoval MA, (1960) [Isolation of Nocardia brasiliensis and asteroides from soils]. Rev Inst Salubr Enferm Trop 20: 147-151.
29. Thirumalachar MJ, Padhye AA, (1968) Isolation of Madurella mycetomi from soil in India. Hindustan Antibiot Bull 10: 314-318.
30. Sotgiu G, Mazzoni A, Mantovani A, Ajello L, Palmer J, (1966) Survey of soils for human pathogenic fungi from the Emilia-Romagna region of Italy. II. Isolation of Allescheria boydii, Cryptococcus neoformans and Histoplasma capsulatum. Am J Epidemiol 83: 329-337.
31. Ajello L, (1952) The isolation of Aliescheria boydii shear, an etiologic agent of mycetomas, from soil. Am J Trop Med Hyg 1: 227-238.
32. Ajello L, Zeidberg LD, (1951) Isolation of Histoplasma capsulatum and Allescheria boydii from soil. Science 113: 662-663.
33. Ahmed A, Adelmann D, Fahal A, Verbrugh H, van Belkum A, et al. (2002) Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Clin Microbiol 40: 1031-1036.
34. de Hoog GS, Abdalla Ahmed S, Najafzadeh MJ, Sutton DA, Saradeghi Keisari M, et al. (2013) Phylogenetic findings suggest possible new habitat and routes of infection of human eumycetoma. PLOS Negl Trop Dis 7: e2229.
35. Fahal AH (2006) Mycetoma, Clinicopathological Monograph. Khartoum: Khartoum University Press.
36. Findlay GH, Vismer HF, (1974) Black grain mycetoma. A study of the chemistry, formation and significance of the tissue grain in Madurella mycetomi infection. Br J Dermatol 91: 297-303.
37. Findlay GH, Vismer HF, (1977) Black grain mycetoma. Atomic absorption and spark source mass spectrophotometry of the tissue grain in Madurella mycetomi infection. Br J Dermatol 97: 497-499.
38. Findlay GH, Vismer HF, Kiebenberg NW, (1979) Black grain mycetoma: the ultrastructure of Madurella mycetomi. Mycopathologia 67: 51-54.
39. Ibrahim AI, El Hassan AM, Fahal A, van de Sande WW, (2013) A histopathological exploration of the Madurella mycetomatis grain. PLOS One 8: e57774.
40. Mahgoub ES, Gumaa SA, El Hassan AM, (1977) Immunological status of mycetoma patients. Bull Soc Pathol Exot Filiales 70: 48-54.
41. van de Sande WW, Fahal A, Verbrugh H, van Belkum A, (2007) Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J Immunol 179: 3065-3074.
42. Mhmoud N, Fahal A, Van de Sande WWJ, (2013) Polymorphisms of interleukin-10 and CCL5 genes in mycetoma. Med Mycol 51: 527-533.
43. Mendez-Tovar LJ, Mondragon-Gonzalez R, Vega-Lopez F, Dockrell HM, Hay R, et al. (2004) Cytokine production and lymphocyte proliferation in patients with Nocardia brasiliensis actinomycetoma. Mycopathologia 158: 407-414.
44. Cavanagh LL, (1974) Attempts to induce mycetoma in monkeys and mice using Madurella mycetomi. Sabouraudia 12: 258-262.
45. Ahmed AO, van Vianen W, ten Kate MT, van de Sande WW, van Belkum A, et al. (2003) A murine model of Madurella mycetomatis eumycetoma. FEMS Immunol Med Microbiol 37: 29-36.
46. Mahgoub ES, (1978) Experimental infection of athymic nude New Zealand mice, nu nu strain with mycetoma agents. Sabouraudia 16: 211-216.
47. van Hellemond JJ, Vonk AG, de Vogel C, Koelewijn R, Vaessen N, et al. (2013) Association of eumycetoma and schistosomiasis. PLOS Negl Trop Dis 7: e2241.
48. Prentice MB, Rahalison L, (2007) Plague. Lancet 369: 1196-1207.
49. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
50. Radolf JD, Caimano MJ, Stevenson B, Hu LT, (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10: 87-99.
51. Kweku MA, Odoom S, Puplampu N, Desewu K, Nuako GK, et al. (2011) An outbreak of suspected cutaneous leishmaniasis in Ghana: lessons learnt and preparation for future outbreaks. Glob Health Action 4doi:10.3402/gha.v4i0.5527.
52. Zhang Y, MacArthur C, Mubila L, Baker S, (2010) Control of neglected tropical diseases needs a long-term commitment. BMC Med 8: 67.
53. Curtis CF, Maxwell CA, Magesa SM, Rwegoshora RT, Wilkes TJ, (2006) Insecticide-treated bed-nets for malaria mosquito control. J Am Mosq Control Assoc 22: 501-506.
54. Mhmoud NA, Ahmed SA, Fahal AH, de Hoog GS, Gerrits van den Ende AH, et al. (2012) Pleurostomophora ochracea, a novel agent of human eumycetoma with yellow grains. J Clin Microbiol 50: 2987-2994.
55. Ahmed AO, Mukhtar MM, Kools-Sijmons M, Fahal AH, de Hoog S, et al. (1999) Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis. J Clin Microbiol 37: 3175-3178.
56. Quintana ET, Wierzbicka K, Mackiewicz P, Osman A, Fahal AH, et al. (2008) Streptomyces sudanensis sp. nov., a new pathogen isolated from patients with actinomycetoma. Antonie Van Leeuwenhoek 93: 305-313.
57. Namangala B, Hachaambwa L, Kajino K, Mweene AS, Hayashida K, et al. (2012) The use of Loop-mediated Isothermal Amplification (LAMP) to detect the re-emerging Human African Trypanosomiasis (HAT) in the Luangwa and Zambezi valleys. Parasit Vectors 5: 282.
58. Matovu E, Kuepfer I, Boobo A, Kibona S, Burri C, (2010) Comparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood. J Clin Microbiol 48: 2087-2090.
59. Surabattula R, Vejandla MP, Mallepaddi PC, Faulstich K, Polavarapu R, (2013) Simple, rapid, inexpensive platform for the diagnosis of malaria by loop mediated isothermal amplification (LAMP). Exp Parasitol 134: 333-340.
60. Verma S, Avishek K, Sharma V, Negi NS, Ramesh V, et al. (2013) Application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis. Diagn Microbiol Infect Dis 75: 390-395.
61. Ablordey A, Amissah DA, Aboagye IF, Hatano B, Yamazaki T, et al. (2012) Detection of Mycobacterium ulcerans by the loop mediated isothermal amplification method. PLOS Negl Trop Dis 6: e1590.
62. Akhoundi B, Mohebali M, Shojaee S, Jalali M, Kazemi B, et al. (2013) Rapid detection of human and canine visceral leishmaniasis: assessment of a latex agglutination test based on the A2 antigen from amastigote forms of Leishmania infantum. Exp Parasitol 133: 307-313.
63. Silveira-Gomes F, Sarmento DN, Pinto TM, Pimentel RF, Nepomuceno LB, et al. (2011) Development and evaluation of a latex agglutination test for the serodiagnosis of paracoccidioidomycosis. Clin Vaccine Immunol 18: 604-608.
64. Attar ZJ, Chance ML, el-Safi S, Carney J, Azazy A, et al. (2001) Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop 78: 11-16.
65. Darani HY, Ahmadi F, Zabardast N, Yousefi HA, Shirzad H, (2010) Development of a Latex Agglutination Test as a Simple and Rapid Method for Diagnosis of Trichomonas vaginalis Infection. Avicenna J Med Biotechnol 2: 63-66.
66. Welsh O, Vera-Cabrera L, Welsh E, Salinas MC, (2012) Actinomycetoma and advances in its treatment. Clin Dermatol 30: 372-381.
67. Zein HA, Fahal AH, Mahgoub el S, El Hassan TA, Abdel-Rahman ME, (2012) Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan. Trans R Soc Trop Med Hyg 106: 639-644.
68. Mahgoub ES, (1976) Medical management of mycetoma. Bull World Health Organ 54: 303-310.
69. Findor JA, Sorda JA, Igartua EB, Avagnina A, (1998) Ketoconazole-induced liver damage. Medicina (B Aires) 58: 277-281.
70. Bernuau J, Durand F, Pessayre D, (1997) Ketoconazole-induced hepatotoxicity. Hepatology 26: 802.
71. van de Sande WWJ, Fahal AH, Bakker-Woudenberg IAJM, van Belkum A, (2010) Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents. Antimicrob Agents Chemother 54: 2738-2740.
72. van de Sande WWJ, Luijendijk A, Ahmed AO, Bakker-Woudenberg IA, van Belkum A, (2005) Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother 49: 1364-1368.
73. Kloezen W, Meis JF, Curfs-Breuker I, Fahal AH, Van de Sande WWJ, (2012) In vitro antifungal activity of isavuconazole to Madurella mycetomatis. Antimicrob Agents Chemother 56: 6054-6056.
74. van Belkum A, Fahal AH, van de Sande WW, (2011) In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine. Antimicrob Agents Chemother 55: 1771-1773.
75. Ahmed AO, van de Sande WWJ, van Vianen W, van Belkum A, Fahal AH, et al. (2004) In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother 48: 2742-2746.
76. Mahgoub ES, Gumaa SA, (1984) Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg 78: 376-379.
77. Fahal AH, Rahman IA, El-Hassan AM, Rahman ME, Zijlstra EE, (2011) The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. Trans R Soc Trop Med Hyg 105: 127-132.
78. Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, et al. (2005) Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47: 339-346.
79. Lacroix C, de Kerviler E, Morel P, Derouin F, Feuilhade de Chavin M, (2005) Madurella mycetomatis mycetoma treated successfully with oral voriconazole. Br J Dermatol 152: 1067-1068.
80. Loulergue P, Hot A, Dannaoui E, Dallot A, Poiree S, et al. (2006) Successful treatment of black-grain mycetoma with voriconazole. Am J Trop Med Hyg 75: 1106-1107.
81. Porte L, Khatibi S, Hajj LE, Cassaing S, Berry A, et al. (2006) Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole. Trans R Soc Trop Med Hyg 100: 891-894.
82. Schaenman JM, Digiulio DB, Mirels LF, McClenny NM, Berry GJ, et al. (2005) Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy. J Clin Microbiol 43: 973-977.
83. N'Diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R, (2006) Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 45: 154-157.
84. Ahmed AO, Abugroun ES, (1998) Unexpected high prevalence of secondary bacterial infection in patients with mycetoma. J Clin Microbiol 36: 850-851.